SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001847903-22-000071
Filing Date
2022-10-14
Accepted
2022-10-14 07:00:19
Documents
13
Period of Report
2022-10-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K cnta-20221013.htm   iXBRL 8-K 37575
  Complete submission text file 0001847903-22-000071.txt   234215

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cnta-20221013.xsd EX-101.SCH 2751
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cnta-20221013_def.xml EX-101.DEF 17043
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cnta-20221013_lab.xml EX-101.LAB 34206
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cnta-20221013_pre.xml EX-101.PRE 18407
7 EXTRACTED XBRL INSTANCE DOCUMENT cnta-20221013_htm.xml XML 15152
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40445 | Film No.: 221310250
SIC: 2834 Pharmaceutical Preparations